Healthpeak Properties (NYSE:DOC) Releases Earnings Results, Misses Estimates By $0.41 EPS

Healthpeak Properties (NYSE:DOC – Get Free Report) issued its earnings results on Monday. The real estate investment trust reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.41), FiscalAI reports. The firm had revenue of $820.89 million during the quarter, compared to the consensus estimate of $739.18 million. Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.46 EPS.

Healthpeak Properties Stock Up 3.2%

NYSE DOC opened at $20.19 on Thursday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 3.02 and a current ratio of 1.29. The company has a market capitalization of $13.92 billion, a P/E ratio of 37.40, a P/E/G ratio of 2.41 and a beta of 1.01. Healthpeak Properties has a one year low of $15.70 and a one year high of $22.95. The stock has a 50 day moving average price of $19.79 and a 200-day moving average price of $19.17.

Healthpeak Properties Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 18th will be given a dividend of $0.1017 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.0%. The ex-dividend date is Friday, December 18th. Healthpeak Properties’s dividend payout ratio is currently 225.93%.

Analyst Ratings Changes

DOC has been the subject of several research analyst reports. Weiss Ratings cut Healthpeak Properties from a “hold (c+)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Cantor Fitzgerald lowered their price target on Healthpeak Properties from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Wednesday. Robert W. Baird upped their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Thursday, August 13th. Citigroup upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 11th. Finally, Barclays cut their price objective on shares of Healthpeak Properties from $24.00 to $21.00 and set an “equal weight” rating for the company in a report on Tuesday, October 13th. Four investment analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties has an average rating of “Hold” and a consensus price target of $21.47.

Read Our Latest Analysis on Healthpeak Properties

Key Headlines Impacting Healthpeak Properties

Here are the key news stories impacting Healthpeak Properties this week:

  • Positive Sentiment: Healthpeak raised its 2026 adjusted FFO guidance to $1.76–$1.78 per share, broadly in line with the $1.77 consensus. Management pointed to outpatient leasing and senior-housing growth, while Q3 revenue rose 16.3% year over year. Zacks article
  • Positive Sentiment: Management described broad operating momentum and expects to lease up recently acquired lab properties over two to three years. A potential recovery in life-science real estate is also cited by analysts as a possible longer-term catalyst. Healthpeak guidance and lab lease-up
  • Neutral Sentiment: Q3 results were mixed: adjusted FFO declined year over year, while revenue increased. Revenue also came in below one reported FactSet estimate, though it exceeded other estimates cited in coverage. Q3 results
  • Negative Sentiment: Refinancing risk remains a concern, and Cantor Fitzgerald cut its price target from $23 to $21 while maintaining a neutral rating. The target reduction may limit enthusiasm despite the improved guidance. Refinancing risk coverage

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.

Read More

Earnings History for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.